NDC 71335-1163 – Buprenorphine HCl

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1163

Product details

Brand name
Buprenorphine HCl
Generic name
Buprenorphine HCl
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA078633
Marketed since
October 8, 2009
Listing expires
December 31, 2026
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine HCl →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1163-0120 TABLET in 1 BOTTLE (71335-1163-0)May 17, 2024
71335-1163-190 TABLET in 1 BOTTLE (71335-1163-1)Mar 21, 2019
71335-1163-260 TABLET in 1 BOTTLE (71335-1163-2)Apr 24, 2019
71335-1163-330 TABLET in 1 BOTTLE (71335-1163-3)Apr 1, 2019
71335-1163-420 TABLET in 1 BOTTLE (71335-1163-4)May 17, 2024
71335-1163-57 TABLET in 1 BOTTLE (71335-1163-5)May 17, 2024
71335-1163-628 TABLET in 1 BOTTLE (71335-1163-6)May 17, 2024
71335-1163-71 TABLET in 1 BOTTLE (71335-1163-7)May 17, 2024
71335-1163-812 TABLET in 1 BOTTLE (71335-1163-8)May 17, 2024
71335-1163-914 TABLET in 1 BOTTLE (71335-1163-9)May 17, 2024

Other Buprenorphine HCl products